For years we’ve been saying that CGM is not just a diabetes management tool but a complete health and wellness tool. That one day people who do not have diabetes will use a CGM as regularly as a Type 1. At the same time, we have accurately pointed out that CGM even with its vast growth has not yet deeply penetrated the diabetes patient population. That even without venturing into new markets there was still plenty of room to grow in diabetes. Suffice to say that is the right problem to have if you are Dexcom or Abbott, the . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.